Publications by authors named "Janik Puttemans"

Claim this Profile
G
Generation and Characterization of Novel Pan-Cancer Anti-uPAR Fluorescent Nanobodies as Tools for Image-Guided Surgery.
Łukasz Mateusiak, Sam Floru, Timo W M De Groof, Janne Wouters, Noemi B Declerck, Janik Puttemans

Adv Sci (Weinh)· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Scrutiny of chimeric antigen receptor activation by the extracellular domain: experience with single domain antibodies targeting multiple myeloma cells highlights the need for case-by-case optimization.
Heleen Hanssens, Fien Meeus, Yannick De Vlaeminck, Quentin Lecocq, Janik Puttemans

Front Immunol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-Idiotypic VHHs and VHH-CAR-T Cells to Tackle Multiple Myeloma: Different Applications Call for Different Antigen-Binding Moieties.
Heleen Hanssens, Fien Meeus, Emma L Gesquiere, Janik Puttemans, Yannick De Vlaeminck

Int J Mol Sci· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeted α-Therapy Using Ac Radiolabeled Single-Domain Antibodies Induces Antigen-Specific Immune Responses and Instills Immunomodulation Both Systemically and at the Tumor Microenvironment.
Thomas Ertveldt, Ahmet Krasniqi, Hannelore Ceuppens, Janik Puttemans, Yana Dekempeneer

J Nucl Med· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Imaging of Glioblastoma Tumor-Associated Myeloid Cells Using Nanobodies Targeting Signal Regulatory Protein Alpha.
Karen De Vlaminck, Ema Romão, Janik Puttemans, Ana Rita Pombo Antunes, Daliya Kancheva

Front Immunol· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Road to Personalized Myeloma Medicine: Patient-specific Single-domain Antibodies for Anti-idiotypic Radionuclide Therapy.
Janik Puttemans, Benoit Stijlemans, Marleen Keyaerts, Sam Vander Meeren, Wim Renmans

Mol Cancer Ther· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CS1-specific single-domain antibodies labeled with Actinium-225 prolong survival and increase CD8+ T cells and PD-L1 expression in Multiple Myeloma.
Kim De Veirman, Janik Puttemans, Ahmet Krasniqi, Thomas Ertveldt, Heleen Hanssens

Oncoimmunology· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Decorating sdAbs with Chelators: Effect of Conjugation on Biodistribution and Functionality.
Henri Baudhuin, Janik Puttemans, Heleen Hanssens, Philippe Vanwolleghem, Sophie Hernot

Pharmaceuticals (Basel)· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Design and Preclinical Evaluation of a Single-Label Bimodal Nanobody Tracer for Image-Guided Surgery.
Pieterjan Debie, Noemi B Declerck, Danny van Willigen, Celine M Huygen, Bieke De Sloovere, Janik Puttemans

Biomolecules· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical Targeted α- and β-Radionuclide Therapy in HER2-Positive Brain Metastasis Using Camelid Single-Domain Antibodies.
Janik Puttemans, Yana Dekempeneer, Jos L Eersels, Heleen Hanssens, Pieterjan Debie

Cancers (Basel)· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Labeling of Anti-HER2 Nanobodies with Astatine-211: Optimization and the Effect of Different Coupling Reagents on Their in Vivo Behavior.
Yana Dekempeneer, Tom Bäck, Emma Aneheim, Holger Jensen, Janik Puttemans

Mol Pharm· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Beyond the Barrier: Targeted Radionuclide Therapy in Brain Tumors and Metastases.
Janik Puttemans, Tony Lahoutte, Matthias D'Huyvetter, Nick Devoogdt

Pharmaceutics· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improved Debulking of Peritoneal Tumor Implants by Near-Infrared Fluorescent Nanobody Image Guidance in an Experimental Mouse Model.
Pieterjan Debie, Marian Vanhoeij, Natalie Poortmans, Janik Puttemans, Kris Gillis

Mol Imaging Biol· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeted alpha therapy using short-lived alpha-particles and the promise of nanobodies as targeting vehicle.
Yana Dekempeneer, Marleen Keyaerts, Ahmet Krasniqi, Janik Puttemans, Serge Muyldermans

Expert Opin Biol Ther· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Particle-mediated Intravenous Delivery of Antigen mRNA Results in Strong Antigen-specific T-cell Responses Despite the Induction of Type I Interferon.
Katrijn Broos, Kevin Van der Jeught, Janik Puttemans, Cleo Goyvaerts, Carlo Heirman

Mol Ther Nucleic Acids· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis